ArticleEuropean radiology experimental2026
Inflammatory and resolution stages of hepatic injury: imaging with USPIO-enhanced MRI in mice.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveLiver injury includes inflammation and resolution stages with different macrophage populations. Hepatic macrophages can be imaged with ultrasmall paramagnetic iron oxide (USPIO) nanoparticles-enhanced magnetic resonance imaging (MRI). We aimed to assess if inflammation and resolution stages of liver injury could be differentiated with USPIO-enhanced MRI in mice. MATERIALS AND
methodsThree groups of C57BL/6JRj mice (control, inflammation, resolution; n = 10 for each group) were imaged. Liver fibrosis was induced by intraperitoneal carbon tetrachloride injections for 6 weeks. Multigradient-echo MRI was performed before, 24, and 48 h after intravenous injection of fluorescent USPIO. Contrast uptake was quantified with
results
conclusionOur results suggest that the inflammatory and resolution stages of hepatic injury can be assessed with USPIO-enhanced MRI. RELEVANCE STATEMENT: Our study demonstrates that USPIO-enhanced MRI can be used to monitor the inflammatory and resolution phases of hepatic injury in mice. If future studies confirm these findings, this imaging method might be valuable for tracking hepatic inflammation dynamics. KEY POINTS: Liver
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.